Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) |
Chief Executive Officer (CEO) |
|
|
Beckman, Peter (Kiel (govt) 201204 Managing Director of KiWi GmbH + KiWi Tower GmbH) |
Managing Director |
|
Germany |
Bissinger, Matthias (Business Angel 202203) |
n. a. |
|
|
Boël, Harold (Sofina 202109 CEO) |
Chief Executive Officer (CEO) |
|
|
Borges, Peter (Business Angel 202302) |
n. a. |
|
|
Brand, Sabine (SBR Consulting 201504) |
Consultant (economic/technology) |
|
Germany |
Brandenberg, Nathalie (Sun Bioscience 202310 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Brandenburg, Mario (Member of German Parliament + Technology Policy Spokesman of FDP) |
n. a. |
|
|
Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) |
Administrative Officer (personnel) |
|
|
Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) |
scientific advisory board (SAB) |
|
|
Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
Colsman, Wolfgang (Zontal 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
Connelly, Robert T. (Elicio Therapeutics 201903– CEO before Pronutria + Pulmatrix + Diversys/Domantis + IGEN Intl) |
Chief Executive Officer (CEO) |
|
|
Cook, Kathryn (NuCicer 202211 CEO + Co-Founder) |
n. a. |
|
|
Dawkins, Keith D. (Shockwave 2019– CMO before Boston Scientific) |
Board member, non-executive |
|
|
Ebert, Eric (Wando Founder) |
n. a. |
|
|
Fratacci, Thomas (SPRIM Global Investments 202302 CFO) |
n. a. |
|
|
Fritz, Jutta (NanoSphere Biotechnologies 202207 CBO before Blackfield + Kinaxo+ Max Planck Innovation) |
Business Development Manager / Strategy Manager |
|
|
Gies, Otto H. (3B Scientifc) |
n. a. |
|
|
Haass, Christian (Professor) |
Professor |
|
|
Hamilton, Amanda (ADC Therapeutics 201911 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
|
|
Hoehnel, Sylke (Sun Bioscience 202310 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Hohmann, Hans-Guenter |
n. a. |
|
|
Hombach, Michael (Univ Zürich 201106 Institute of Medical Microbiology) |
n. a. |
|
|
Horn, Friedemann (Univ Leipzig 201602 Professor at Faculty of Medicine + Co-Founder Ribolution Health GmbH) |
n. a. |
|
|
Janositz, Paul |
journalism |
|
|
Johnson, Wendy (Gemini Advisors 201503 Managing Director before ProQuest Investments + Aires Pharmaceuticals) |
Managing Director |
|
|
Jones, David T. W. (Heidelberg Epignostix 202407 General Manager + Co-Founder) |
Managing Director |
|
|
Khaljani, Ehsan |
n. a. |
|
|
Knorr, Till (Business Angel) |
n. a. |
|
|
Kreibohm, Philipp (Home24 Founder) |
n. a. |
|
|
Kurian, Thomas (Alphabet 201906 CEO of Google Cloud) |
n. a. |
|
|
Leo, Giovanni (EFI Lake Geneva Ventures I 202306 Partner + EBAMed 202306 Co-Founder + Chair) |
Partner (venture partner) |
|
|
Lokey, Houlihan |
consulting (economic) |
|
|
Lukesch, Michael (Valanx Biotech 202311 CEO + Founder) |
n. a. |
|
|
Maier, Elmar (EM Biotech 2009– CEO + Founder before iOmx Therapeutics + GPC Biotech) |
Chief Executive Officer (CEO) |
|
Germany |
Maier, Robert (ladenzeile.de Founder) |
n. a. |
|
|
Murmann, Lucas (SVM (DE) 202012 Investment Manager at SVM Verwaltungsgesellschaft mbH) |
Investment Manager |
|
Germany |
Otto, Michael (Otto Group 201502) |
n. a. |
|
|
Pejowski, David (Adoram Therapeutics 202210 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Peters, Andreas C. (GSK Stockmann 201704 Lawyer at Hamburg Office) |
Attorney / Lawyer |
|
|
Roskopf, Oliver (Vitafy Founder + Zalando Founder) |
n. a. |
|
|
Rost, Martin (Zalando Founder) |
n. a. |
|
|
Rule, Chelsea (MacDougall Advisors 202305) |
n. a. |
|
|
Röder, Albert (StemVac GmbH 201602– Managing Director) |
Managing Director |
|
|
Schaback, Johannes (ladenzeile.de Founder + Home24 Founder) |
n. a. |
|
|
Schaffarczyk, Dietmar Stefan (stimOS GmbH 201707 Managing Director) |
Managing Director |
|
|
Schmidt, Pascal (Marinomed 201808– CFO before Raymond James Financial + Mummert & Co + Infineon Ventures) |
Chief Financial Officer (CFO) |
|
|
Schulte-Noelle, Philipp |
n. a. |
|
|
Schwarz, Kurt (from founding family of Schwarz Pharma AG) |
Investment Manager |
|
|
Sheridan, Jonathan M. (Biomax Informatics 201410– CEO of US subsidiary before Integrated Genomics + HGT + Epicentre) |
Chief Executive Officer (CEO) |
|
|
Shoffner, John |
n. a. |
|
|
Simmat, Olaf (QInstruments 202110 CEO + Co-Founder) |
Managing Director |
|
|
Songhurst, Charlie |
n. a. |
|
|
Stoll, Dwight (Gastavus Adolphus College, Minnesota 201704 Associate Professor) |
Professor |
|
|
Summerton, Linda (Immodulon Therapeutics 201702 CEO + TranScrip before Merck KGaA + AstraZeneca) |
Chief Executive Officer (CEO) |
|
|
Swanepoel, Lisa (Bruker 201008 Bruker South Africa + SAAMS) |
n. a. |
|
South Africa |
Tamkivi, Sten |
n. a. |
|
|
Topp, Thomas (Cochlear 201009 Cochlear Deutschland GmbH & Co KG) |
n. a. |
|
|
Trojer, Patrick (Triana Biomedicines 202410 CEO + Board Chair at Booster Therapeutics) |
Chief Executive Officer (CEO) |
|
|
Tzannis, Stelios T. (Aeovian Pharmaceuticals 201910 CEO) |
Chief Executive Officer (CEO) |
|
|
Valdenaire, Olivier (Mestex 2014– CEO) |
Chief Executive Officer (CEO) |
|
|
van den Oever, Jeroen (Sun Bioscience 202310 CFO) |
Chief Executive Officer (CEO) |
|
Switzerland |
Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director) |
Managing Director |
|
|
Wendeln, Bernd |
n. a. |
|
|
Wiech, Hans (Camoleon Knowledge Brokerage 201108) |
n. a. |
|
|
Wilmanns, Max (GSK Stockmann 201704 Lawyer + Partner at Hamburg Office) |
Attorney / Lawyer |
|
|
Wohlers, Katja |
n. a. |
|
|
Wüller, Conrad (ArtBio 202401 Director Strategy + Operations) |
Business Development Manager / Strategy Manager |
|
|
Yan, Zhiyu (Alan) (Sperogenix Therapeutics 202201 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) |
Chief Executive Officer (CEO) |
|
|
Young, Jordan (Repare Therapeutics 202305 Director of SNIPRx platform) |
n. a. |
|
|
Zilch, Christian Frank (Magna Diagnostics GmbH 201512 Managing Director) |
Managing Director |
|
|
Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) |
Managing Partner (investment firm) |
+ND Capital (f.k.a. NanoDimension) |
Switzerland |
Thelen, Frank (10xDNA 202308 Managin Director of 10xDNA Capital Partners GmbH) |
Managing Director |
10xDNA (Group) |
Germany |
Vogler, Marcel (10xDNA 202308 Managin Director of 10xDNA Capital Partners GmbH) |
Managing Director |
10xDNA (Group) |
Germany |
Engleman, Katie (1AB Media 201903 before Pure Communications) |
Public Relations Manager / Investor Relations Manager |
1AB Media (US) |
United States (USA) |
Kretzschmar, Titus (1abtik AG 201510– CEO + Founder) |
Chief Executive Officer (CEO) |
1abtik AG |
Switzerland |
Krapinger-Rüther, Bastian (1BillionLives 202410 Managing Director + Co-Founder) |
Managing Director |
1BillionLives GmbH (d/b/a Flinn) |
Austria |
Müller, Martin (1BillionLives 202410 Managing Director) |
Managing Director |
1BillionLives GmbH (d/b/a Flinn) |
Austria |
Reichen, Steven (1BillionLives 202410 Sales + Bsuiness Developm,ent) |
Sales Manager / Marketing Manager |
1BillionLives GmbH (d/b/a Flinn) |
Austria |
Samad, Hasib (1BillionLives 202410 Managing Director) |
Managing Director |
1BillionLives GmbH (d/b/a Flinn) |
Austria |
Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
Netherlands |
Hibbs, Kathy L. (23andMe 202101 Chief Legal + Regulatory Officer before Genomic Health + Monogram Biosciences) |
General Counsel / Chief Legal Officer (CLO) |
23andMe Inc. |
United States (USA) |
Schubert, Thomas (2bind GbmH 202209 CEO) |
Chief Executive Officer (CEO) |
2bind GmbH |
Germany |
Andreu, Fernando (2curex 202101– before Indivumed + Sysmex Inostics) |
Chief Executive Officer (CEO) |
2cureX (Group) |
Denmark |
Johansen, Kenneth Graabek (2cureX 202102– CFO before JADBio + Raven Biosciences + Qiagen Aarhus + CLC bio) |
Chief Financial Officer (CFO) |
2cureX (Group) |
Sweden |
Bach, Alfred (Axaron/Sygnis 200511–201010 CEO resigned 10/10 before BASF + Genentech) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
del Castillo, Juan Carlos (Genetrix 201207 Operations Director) |
Chief Operating Officer (COO) |
2invest (Group) |
Spain (España) |
Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
Hacke, Werner (Lion 200603) |
Board member, non-executive |
2invest (Group) |
Germany |
Haubner, Ralph (Axaron 200307– CFO before Boehringer Ingelheim + GD Searle + Fresenius + Biotest) |
Chief Financial Officer (CFO) |
2invest (Group) |
Germany |
Lanckriet, Heikki (Expedeon 201111 CEO + Founder) |
Chief Executive Officer (CEO) |
2invest (Group) |
United Kingdom (GB) |
Lansky, Frank |
n. a. |
2invest (Group) |
Germany |
Mulet, Miguel (Genetrix 201207 Business Development Director before Janssen Pharmaceutica + co-founder of Mirada) |
Business Development Manager / Strategy Manager |
2invest (Group) |
Spain (España) |
Rathgeb, Frank (Sygnis Pharma 201109 CMO) |
Chief Medical Officer (CMO) |
2invest (Group) |
Germany |
Roth, David (Genetrix (ES) 201703– CFO at Sygnis AG before KPMG + Deloitte + Arthur Andersen in the UK) |
Chief Financial Officer (CFO) |
2invest (Group) |
Germany |
Thomas, Neil (Genetrix 2006– IP Director before bioXell SpA) |
IP Manager |
2invest (Group) |
Spain (España) |